News, Articles & Media

Posts Tagged ‘Newsletter’

September 2015 Newsletter to Shareholders

Read the September 2015 Newsletter for news on the following:

  • The Quarterly Review of Scientific Progress, including first data on the accuracy of Caldera’s diagnostic text, the move to automation of the test, and an update on development of Caldera’s urine prostate cancer test
  • Caldera’s Business Information document, outlining the business plan for 2016
  • The Annual Meeting of Shareholders in late October

May 2015 Newsletter to Shareholders

Read the May 2015 Newsletter for news on the following:

  • The appointment of a new Director of Research and Development
  • Our recent project review,
  • The R&D growth grant we received from Callaghan Innovation
  • Migrating our accounting system to the cloud
  • Two further staff appointments.

This newsletter also contains a third article on prostate cancer from Dr Jim Watson.

November 2014 Newsletter to Shareholders

Read the November 2014 newsletter for updates on new premises, Clinical Study 2, new investment, accounting, new staff, the Annual Meeting.

This newsletter also contains the second of Dr Jim Watson’s opinion pieces on prostate cancer.

August 2014 Newsletter to Shareholders

Read the August 2014 newsletter for updates on new investment, R&D grants from Callaghan Innovation, Clinical Study 2, collaboration with Malaghan Institute, accounting, new premises, new staff and Chiasma – an Auckland University student-led organisation fostering connections between science and business.

This newsletter also contains the first of Dr Jim Watson’s opinion pieces about prostate cancer.

May 2014 Newsletter to Shareholders

Read the May 2014 newsletter for updates on the pro-rata share issue and Clinical Trial 2 progress.

April 2014 Newsletter to Shareholders

Read the April 2014 newsletter for updates on where we have been, where we are today, where we are going and the way forward.

February 2014 Newsletter to Shareholders

Read the February 2014 newsletter for updates on capital raising and science progress.

October 2013 Newsletter to Shareholders

Read the October 2013 newsletter for updates on new staff, Clinical Study 1 and patents.